The dynamic changes observed in key mutations such as BRAF, APC, GNAS, EGFR, and PIK3CA suggest that ctDNA analysis can offer unique insights into tumor evolution that are not captured by traditional tissue biopsies. This evidence concerns the gene BRAF and neoplasm.